Table 2

Prediction of progression based on Cox proportional hazards models using the baseline data for all variables

Adjusted forAdjusted for the model and
Variable and adjustmentUnadjusted or adjusted for sexTotal cholesterolSmoking historyHbA1cWHRTGseGFRAdjusted for PMAERKIM-1L-FABPSerum ADP
Normal AER
 uADP
  No1.32
(<0.001)1.29
(0.002)1.31
(0.001)1.17
(0.07)1.40
(<0.001)1.22
(0.02)0.98
(0.80)0.96
(0.76)0.98
(0.90)1.22
(0.07)
  Sex1.39
(<0.001)1.36
(<0.001)1.39
(<0.001)1.24
(0.01)1.42
(<0.001)1.25
(0.01)0.99
(0.91)0.97
(0.81)1.01
(0.94)1.26
(0.04)
Microalbuminuria
 uADP
  No1.38
(0.007)1.29
(<0.05)1.45
(0.002)1.37
(0.008)1.34
(0.03)1.01
(0.95)1.31
(0.07)1.02
(0.92)1.30
(0.14)
  Sex1.46
(0.001)1.35
(0.02)1.46
(0.001)1.42
(0.003)1.35
(0.02)1.02
(0.89)1.31
(0.06)1.04
(0.83)1.29
(0.15)
Macroalbuminuria
 uADP
  No2.03
(<0.0001)1.98
(<0.001)1.50
(<0.001)1.51
(<0.001)1.30
(0.03)1.47
(<0.001)1.36
(0.002)1.39
(0.001)
  Sex2.05
(<0.0001)2.01
(<0.001)1.50
(<0.001)1.52
(<0.001)1.37
(0.01)1.29
(0.001)1.39
(0.001)1.36
(0.001)
  • Data are HR (P value). The basic models for progression for every stage derived from Cox proportional hazards models were used. The full description of the model-building process is provided in the research design and methods. No, models without any adjustments; PM, progression model; Sex, models adjusted for sex; TG, triglyceride; WHR, waist-to-hip ratio.